Current Value
$440.451 Year Return
Current Value
$440.451 Year Return
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
VIXY | -34.95% | $165.69M | 0.85% |
TAIL | -20.90% | $99.76M | 0.59% |
BTAL | -17.10% | $296.79M | 1.43% |
CLIP | -14.06% | $1.52B | 0.07% |
IVOL | -11.18% | $351.30M | 1.02% |
TPMN | -9.10% | $30.77M | 0.65% |
XHLF | -7.26% | $1.73B | 0.03% |
BILS | -6.84% | $3.86B | 0.1356% |
UNG | -6.73% | $359.91M | 1.06% |
GBIL | -6.41% | $6.40B | 0.12% |
TBLL | -5.36% | $2.14B | 0.08% |
ULST | -4.36% | $662.59M | 0.2% |
BNO | -4.23% | $103.68M | 1% |
USO | -4.21% | $1.18B | 0.6% |
BIL | -4.10% | $42.87B | 0.1356% |
USDU | -3.93% | $162.92M | 0.5% |
KCCA | -3.67% | $104.88M | 0.87% |
OILK | -3.55% | $71.89M | 0.69% |
DBE | -3.50% | $51.16M | 0.77% |
USL | -3.17% | $42.26M | 0.85% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
DBC | -0.03% | $1.21B | 0.87% |
PDBC | 0.08% | $4.37B | 0.59% |
GLDM | 0.11% | $15.83B | 0.1% |
STOT | -0.12% | $253.88M | 0.45% |
BILZ | -0.17% | $827.49M | 0.14% |
BAR | 0.22% | $1.12B | 0.1749% |
IBTH | 0.34% | $1.60B | 0.07% |
SGOL | 0.37% | $5.22B | 0.17% |
GSG | -0.38% | $961.35M | 0.75% |
TFLO | -0.38% | $6.86B | 0.15% |
COMT | -0.38% | $603.56M | 0.48% |
CANE | 0.49% | $10.44M | 0.29% |
SPTS | -0.51% | $5.78B | 0.03% |
GLD | 0.57% | $101.85B | 0.4% |
IAU | 0.58% | $47.14B | 0.25% |
UGA | -0.62% | $72.51M | 0.97% |
AAAU | 0.63% | $1.54B | 0.18% |
KBA | -0.67% | $176.19M | 0.56% |
BOXX | -0.69% | $6.72B | 0.19% |
UTWO | 0.69% | $379.36M | 0.15% |
Double maintains 13 strategies that include VRTX - Vertex Pharmaceuticals, Inc.
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
KRYS | 49.06% | $4.01B | -24.37% | 0.00% |
AMGN | 42.21% | $149.01B | -11.30% | 3.34% |
ABBV | 40.54% | $322.03B | +6.29% | 3.50% |
REGN | 40.43% | $56.25B | -50.43% | 0.17% |
PFE | 40.38% | $137.53B | -13.55% | 7.04% |
SNDX | 39.93% | $777.87M | -55.97% | 0.00% |
TECH | 39.60% | $8.13B | -27.65% | 0.62% |
IDYA | 39.29% | $1.87B | -39.13% | 0.00% |
CSGP | 38.93% | $34.07B | +8.93% | 0.00% |
MFA | 38.23% | $989.57M | -9.40% | 15.06% |
ROIV | 38.04% | $7.74B | +7.76% | 0.00% |
RGNX | 37.94% | $422.76M | -28.29% | 0.00% |
AVY | 37.39% | $13.73B | -19.68% | 2.04% |
PRAA | 37.29% | $598.45M | -23.25% | 0.00% |
BIIB | 37.28% | $18.47B | -45.61% | 0.00% |
IMNM | 37.12% | $763.10M | -27.52% | 0.00% |
AVB | 36.79% | $29.10B | -1.21% | 3.39% |
CTAS | 36.62% | $89.14B | +26.10% | 1.23% |
CBRE | 36.58% | $41.55B | +56.41% | 0.00% |
CGON | 36.38% | $1.98B | -17.80% | 0.00% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
BBH | 61.43% | $329.40M | 0.35% |
IBB | 58.80% | $5.36B | 0.45% |
FBT | 52.13% | $1.01B | 0.54% |
VHT | 51.97% | $15.31B | 0.09% |
FHLC | 51.21% | $2.42B | 0.084% |
IXJ | 51.20% | $3.72B | 0.41% |
IYH | 51.08% | $2.71B | 0.39% |
XLV | 51.07% | $34.14B | 0.09% |
XBI | 51.04% | $4.95B | 0.35% |
PBE | 48.21% | $223.16M | 0.58% |
PPH | 46.41% | $590.55M | 0.36% |
PINK | 45.87% | $133.06M | 0.5% |
RSPH | 45.54% | $727.92M | 0.4% |
FXH | 44.54% | $898.02M | 0.62% |
IHE | 44.50% | $557.07M | 0.39% |
GNOM | 43.32% | $44.21M | 0.5% |
XPH | 41.60% | $149.79M | 0.35% |
FDLO | 40.25% | $1.21B | 0.16% |
USMV | 39.88% | $23.56B | 0.15% |
OUSA | 39.67% | $803.50M | 0.48% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
AIFU | -18.20% | $6.13B | +82.50% | 0.00% |
SHCO | -17.32% | $1.43B | +38.42% | 0.00% |
MQ | -13.01% | $2.75B | +7.30% | 0.00% |
CPSH | -11.28% | $40.67M | +64.71% | 0.00% |
CNK | -11.06% | $3.46B | +39.22% | 0.53% |
DHC | -9.55% | $858.85M | +16.72% | 1.11% |
AORT | -9.03% | $1.33B | +21.60% | 0.00% |
MNOV | -8.45% | $65.23M | -7.64% | 0.00% |
QNRX | -8.34% | $5.45M | -54.34% | 0.00% |
LMB | -8.31% | $1.62B | +144.84% | 0.00% |
USM | -8.29% | $5.32B | +12.04% | 0.00% |
STG | -7.96% | $29.06M | -28.79% | 0.00% |
TDS | -7.32% | $3.92B | +65.51% | 0.46% |
EVGO | -6.81% | $499.11M | +51.84% | 0.00% |
FARO | -6.63% | $849.75M | +174.94% | 0.00% |
TIMB | -6.15% | $9.41B | +37.31% | 2.66% |
MESO | -5.71% | $1.39B | +60.35% | 0.00% |
FATBB | -5.60% | $45.45M | -14.20% | 11.38% |
BTCT | -5.43% | $18.98M | +37.85% | 0.00% |
OMER | -5.30% | $187.50M | -21.18% | 0.00% |
Finnhub
Vertex said on Tuesday thatits next-generation drug gained European Commission approval fortreating cystic fibrosis, a rare and progressive geneticdisease. The approval expands the...
Finnhub
Vertex said on Tuesday that its next-generation drug, Alyftrek, gained European Commission approval for the treatment of cystic fibrosis. CF is an inherited disorder resulting from the...
Finnhub
ALYFTREK® approved in the EU for people with CF 6 years and older with at least one non-class I mutation in the CFTR gene, making it the broadest label for this medicine in the world -- In...
Yahoo
(Reuters) -AbbVie said on Monday it would acquire privately held cell therapy developer Capstan Therapeutics in a deal worth up to $2.1 billion, expanding its product pipeline with experimental treatments for autoimmune diseases. The U.S. drugmaker has spent over $20 billion on acquisitions since 2023 as its flagship rheumatoid arthritis drug, Humira, lost patent protection. Capstan develops CAR-T therapies, which use a patient's own immune cells, specifically T-cells, to fight diseases.
Yahoo
VRTX slips 9% in three months on slow new drug uptake and pipeline hiccups, but CF strength and 2025 growth offer a reason to hold.
Finnhub
Vertex Pharmaceuticals Incorporated added to Russell 1000 Dynamic Index...
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
CRMD | -0.04% | $847.81M | +188.68% | 0.00% |
ATUS | 0.07% | $996.26M | +4.41% | 0.00% |
CCJ | 0.07% | $31.90B | +48.92% | 0.15% |
UEC | -0.11% | $2.98B | +11.65% | 0.00% |
ANF | 0.14% | $3.94B | -53.49% | 0.00% |
IIIV | 0.22% | $644.61M | +19.72% | 0.00% |
ALTO | 0.23% | $88.02M | -21.11% | 0.00% |
AQB | -0.25% | $2.84M | -54.35% | 0.00% |
CEG | 0.28% | $100.35B | +59.87% | 0.46% |
BEKE | -0.35% | $21.25B | +31.02% | 1.99% |
HDSN | -0.35% | $348.72M | -8.76% | 0.00% |
ZCMD | -0.38% | $28.79M | -13.64% | 0.00% |
RLX | -0.46% | $2.02B | +20.65% | 0.45% |
VIV | 0.50% | $18.00B | +40.27% | 0.69% |
AMPY | -0.51% | $134.32M | -50.89% | 0.00% |
BPT | -0.51% | $11.00M | -79.19% | 0.00% |
CE | 0.54% | $6.21B | -57.91% | 2.58% |
SAVA | 0.56% | $84.54M | -85.83% | 0.00% |
QXO | 0.59% | $11.99B | -71.11% | 0.00% |
UPWK | 0.61% | $1.79B | +26.79% | 0.00% |